Home LiteratureArticle Details
PMID: 3109949 Published · ppublish English Journal Article

Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells.

FEBS letters ·Vol. 218 ·No. 2 ·1987-06-29 ·Pages 292-4

Glukhova MA, Kabakov AE, Ornatsky OI, Vasilevskaya TD, Koteliansky VE, Smirnov VN

Abstract

150 kDa caldesmon was shown to be characteristic of vascular smooth muscle cells in normal tissue rather than in subculture. Subcultured smooth muscle cells from human aorta contained only the 70 kDa immunoreactive form of caldesmon. During the course of primary culture the amount of 150 kDa caldesmon as well as metavinculin decreased significantly whilst 70 kDa caldesmon became the predominant form, and by the onset of cell division the 150 kDa form was practically substituted by 70 kDa caldesmon. The data show that the predominance of 150 kDa caldesmon is characteristic of contractile smooth muscle cells, while in proliferating cells 70 kDa caldesmon is expressed.

MeSH Terms
Aorta Calmodulin-Binding Proteins/analysis Cells, Cultured Contractile Proteins/analysis Filamins Humans Immunosorbent Techniques Microfilament Proteins/analysis Muscle Proteins/analysis Muscle, Smooth, Vascular/analysis Vinculin
Chemicals
Calmodulin-Binding Proteins Contractile Proteins Filamins Microfilament Proteins Muscle Proteins Vinculin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Glukhova M A
Kabakov A E
Ornatsky O I
Vasilevskaya T D
Koteliansky V E
Smirnov V N
Article Info
Journal
FEBS letters
Abbr.
FEBS Lett
ISSN
0014-5793
Published
1987-06-29
Pages
292-4
Language
English
Region
England
NLM ID
0155157
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]